We offer a full range of specialized pulmonary function tests supported by key opinion leaders. We are flexible and work with you to develop customized solutions for the unique nature of trials in rare and orphan diseases.
We provide:
We have provided flexible and specialist support to rare disease clinical trials and orphan disease clinical trials. Examples include: Duchenne Muscular Dystrophy (DMD), POMPE, Limb-Girdle Muscular Dystrophy and Systemic lupus erythematosus (SLE).
Our flexible and adaptable systems allow us to deliver data tailored to your requirements for Phase I – IV, adult and pediatric trials. We work closely with KOLs who can support your protocol development.
Internationally renowned Over-readers ensure high-quality data and feedback for your trial, which improves site data, compliance, and performance.
A highly qualified and responsive team of project and data managers will be dedicated to your study, allowing for informed decisions to be made quickly and for prompt response and feedback to any queries. It also ensures key milestones and timelines are met.
We assure the rapid delivery of your rare or orphan disease clinical trial.
Criteria | Example Endpoints |
---|---|
Subjective Endpoints |
|
Objective Endpoints |
|
Speak to our team about our experience and how our services can benefit your study.
Vitalograph is a global leader in respiratory diagnostics. We produce high quality, accurate and reliable, respiratory medical devices & services for primary, secondary healthcare and occupational health. We deliver successful clinical trials for leading pharmaceutical companies, biotechs and research organizations.
© Vitalograph 2011 – 2021 | Privacy Policy | Cookies
Vitalograph Inc
13310 W. 99th St.
Lenexa, KS 66215
United States
E: clinical.trials@vitalograph.com
Toll Free: 1-800-255-6626
Make sure you understand the international safety guidelines for spirometry testing by downloading our 5 Key Considerations Guide and order your FREE trial pack of Bacterial Viral Filters to help you test safely.